1. Reichert JM (2001) Monoclonal antibodies in the clinic. Nat Biotechnol 19:819–822
2. Reichert JM, Pavolu A (2004) Monoclonal antibodies market. Nat Rev Drug Discov 3:383–384
3. Drapeau M, Sullivan F, Moniz Carpenter J (2007) Special report: blockbuster then and now–trends for billion-dollar drugs. Spectr Ther Markets Emerg Technol 12:1–39
4. Munos B (2009) Lessons from 60 years of pharmaceutical innovation. Nat Rev 8:959–968
5. Doig AR, Ecker DM, Ransohoff TC (2015) Monoclonal antibody targets and indications. Am Pharm Rev 15:177490